Joel Greshock

10.0k total citations · 1 hit paper
63 papers, 4.0k citations indexed

About

Joel Greshock is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Joel Greshock has authored 63 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 23 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Joel Greshock's work include Cancer Genomics and Diagnostics (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Gene expression and cancer classification (10 papers). Joel Greshock is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and Gene expression and cancer classification (10 papers). Joel Greshock collaborates with scholars based in United States, China and United Kingdom. Joel Greshock's co-authors include Barbara Weber, Tara L. Naylor, George Coukos, Jia Huang, Dionyssios Katsaros, Shun Liang, Lin Zhang, Antonis Giannakakis, Ann O’Brien-Jenkins and Nuo Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Joel Greshock

60 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

microRNAs exhibit high frequency genomic alterations in human cancer

2006 829 citations Lin Zhang, Jia Huang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joel Greshock United States	27	2.7k	1.7k	979	657	393	63	4.0k
Andrew D. Cherniack United States	30	2.6k 1.0×	1.2k 0.7×	967 1.0×	576 0.9×	272 0.7×	73	3.9k
Koei Chin United States	27	2.2k 0.8×	1.0k 0.6×	876 0.9×	812 1.2×	244 0.6×	65	3.4k
Jon W. Teague United Kingdom	15	3.1k 1.1×	1.7k 1.0×	1.2k 1.3×	782 1.2×	265 0.7×	24	4.5k
Maija Wolf Finland	28	2.4k 0.9×	1.1k 0.7×	739 0.8×	832 1.3×	184 0.5×	45	3.6k
Wen-Lin Kuo United States	22	3.4k 1.3×	987 0.6×	1.4k 1.4×	659 1.0×	198 0.5×	30	4.7k
Charlotte G. Cole United Kingdom	18	3.5k 1.3×	1.9k 1.1×	1.0k 1.0×	850 1.3×	245 0.6×	33	5.0k
Dieter Niederacher Germany	38	2.4k 0.9×	1.4k 0.8×	1.6k 1.7×	854 1.3×	242 0.6×	143	4.2k
Simone Petersen Germany	23	2.5k 0.9×	845 0.5×	822 0.8×	509 0.8×	380 1.0×	30	3.6k
Peter M. Haverty United States	29	2.4k 0.9×	677 0.4×	846 0.9×	389 0.6×	298 0.8×	38	3.3k
Zhigang C. Wang United States	16	2.6k 0.9×	1.1k 0.6×	1.9k 1.9×	536 0.8×	400 1.0×	22	3.9k

Countries citing papers authored by Joel Greshock

Since Specialization

Citations

This map shows the geographic impact of Joel Greshock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Greshock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Greshock more than expected).

Fields of papers citing papers by Joel Greshock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Greshock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Greshock. The network helps show where Joel Greshock may publish in the future.

Co-authorship network of co-authors of Joel Greshock

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Greshock. A scholar is included among the top collaborators of Joel Greshock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Greshock. Joel Greshock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sweiti, Hussein, Spyros Triantos, Shibu Thomas, et al.. (2023). 192P Impact of oncogenic fibroblast growth factor receptor (FGFR) alterations in patients with advanced solid tumors in a real-world setting. Annals of Oncology. 34. S259–S259.

Horn, Thomas, Stéphane Ferretti, Nicolas Ebel, et al.. (2016). High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Research. 76(23). 6950–6963. 24 indexed citations

Nathanson, Katherine L., Anne‐Marie Martin, Bradley Wubbenhorst, et al.. (2013). Tumor Genetic Analyses of Patients with Metastatic Melanoma Treated with the BRAF Inhibitor Dabrafenib (GSK2118436). Clinical Cancer Research. 19(17). 4868–4878. 132 indexed citations

Kim, Nayoung, Ningning He, Chang Sik Kim, et al.. (2012). Systematic analysis of genotype‐specific drug responses in cancer. International Journal of Cancer. 131(10). 2456–2464. 27 indexed citations

Jing, Junping, Joel Greshock, Joanna D. Holbrook, et al.. (2011). Comprehensive Predictive Biomarker Analysis for MEK Inhibitor GSK1120212. Molecular Cancer Therapeutics. 11(3). 720–729. 96 indexed citations

Kaur, Sippy, Joel Greshock, Heini Lassus, et al.. (2011). A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer. Cancer Research. 72(1). 154–164. 44 indexed citations

Degenhardt, Yan, Joel Greshock, Sylvie Laquerre, et al.. (2010). Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability. Molecular Cancer Therapeutics. 9(7). 2079–2089. 73 indexed citations

Greshock, Joel, Kurtis E. Bachman, Yan Degenhardt, et al.. (2010). Molecular Target Class Is Predictive of In vitro Response Profile. Cancer Research. 70(9). 3677–3686. 100 indexed citations

Liu, Li, James Greger, Hong Shi, et al.. (2009). Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL. Cancer Research. 69(17). 6871–6878. 378 indexed citations

10.

Qian, Fawn, Stefan Engst, Toshihiro Yamaguchi, et al.. (2009). Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases. Cancer Research. 69(20). 8009–8016. 282 indexed citations

11.

Greshock, Joel, Jie Cheng, David W. Rusnak, et al.. (2008). Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines. Molecular Cancer Therapeutics. 7(4). 935–943. 18 indexed citations

12.

Giannakakis, Antonis, Raphael Sandaltzopoulos, Joel Greshock, et al.. (2008). miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biology & Therapy. 7(2). 255–264. 291 indexed citations

13.

Greshock, Joel, Bin Feng, Cristina Nogueira, et al.. (2007). A Comparison of DNA Copy Number Profiling Platforms. Cancer Research. 67(21). 10173–10180. 54 indexed citations

14.

Greshock, Joel, Katherine L. Nathanson, Anne‐Marie Martin, et al.. (2007). Cancer Cell Lines as Genetic Models of Their Parent Histology: Analyses Based on Array Comparative Genomic Hybridization. Cancer Research. 67(8). 3594–3600. 56 indexed citations

15.

Degenhardt, Yan, Katja Remlinger, Joel Greshock, et al.. (2006). Biomarker analyses of PLK isoforms in breast cancer. Cancer Research. 66. 459–459. 1 indexed citations

16.

Naylor, Tara L., Joel Greshock, Yan Wang, et al.. (2005). High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Research. 7(6). R1186–98. 165 indexed citations

17.

Mossé, Yaël P., Joel Greshock, Barbara L. Weber, & John M. Maris. (2005). Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era. Cancer Letters. 228(1-2). 83–90. 13 indexed citations

18.

Bignell, Graham R., Jing Huang, Joel Greshock, et al.. (2004). High-Resolution Analysis of DNA Copy Number Using Oligonucleotide Microarrays. Genome Research. 14(2). 287–295. 281 indexed citations

19.

Greshock, Joel, Tara L. Naylor, Adam A. Margolin, et al.. (2003). 1-Mb Resolution Array-Based Comparative Genomic Hybridization Using a BAC Clone Set Optimized for Cancer Gene Analysis. Genome Research. 14(1). 179–187. 88 indexed citations

20.

Mossé, Yaël P., Joel Greshock, Allison A. King, et al.. (2003). Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. The Lancet Oncology. 4(12). 769–771. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact